Inventor · disambiguated record
Zhong-Yin Zhang
Also filed as: ZHANG ZHONG · ZHANG ZHONG-YIN
21 granted patents·7 pending applications·62 citations·filing 2002–2024
92Inventor score
Files withUNIV INDIANA RES & TECH CORP7PURDUE RESEARCH FOUNDATION4TRANSFORM PHARMACEUTICALS INC4ZHANG ZHONG-YIN3ZHANG ZHONG2
Top patents by PatentIndex Score
28 records- 0187US8637684B2Tautomycetin and tautomycetin analog biosynthesisSHEN BEN·Filed 2011·Granted Jan 28, 2014·14 cites·38 claims
- 0286US8815950B2Pharmaceutical compositions and method of using levodopa and carbidopaREMENAR JULIUS·Filed 2005·Granted Aug 26, 2014·11 cites·23 claims
- 0385US8133918B2Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their usesZHANG ZHONG·Filed 2008·Granted Mar 13, 2012·7 cites·29 claims
- 0482US9522881B2Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)UNIV INDIANA RES & TECH CORP·Filed 2014·Granted Dec 20, 2016·7 cites·20 claims
- 0582US7550155B2Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their usesTRANSFORM PHARMACEUTICALS INC·Filed 2004·Granted Jun 23, 2009·14 cites·48 claims
- 0677US10072043B2Inhibitors of protein tyrosine phosphatasesUNIV INDIANA RES & TECH CORP·Filed 2015·Granted Sep 11, 2018·2 cites·9 claims
- 0773US7736911B2Activity-based probes for protein tyrosine phosphatasesEINSTEIN COLL MED·Filed 2005·Granted Jun 15, 2010·4 cites·17 claims
- 0870US9217012B2Inhibitors of protein tyrosine phosphatasesZHANG ZHONG-YIN·Filed 2010·Granted Dec 22, 2015·2 cites·5 claims
- 0967US11814396B2Sesquiterpenoid analogsPURDUE RESEARCH FOUNDATION·Filed 2021·Granted Nov 14, 2023·0 cites·2 claims
- 1066US9844535B2SHP2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitorsUNIV INDIANA RES & TECH CORP·Filed 2014·Granted Dec 19, 2017·0 cites·5 claims
- 1163US12426614B2Lentinula edodes-derived saltiness enhancing peptide, method for preparing the same and use thereofSHANGHAI ACAD AGRI SCIENCES·Filed 2024·Granted Sep 30, 2025·0 cites·10 claims
- 1263US10092543B2Methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitorsUNIV INDIANA RES & TECH CORP·Filed 2017·Granted Oct 9, 2018·0 cites·13 claims
- 1363US7915317B2Aqueous 2,6-diisopropylphenol pharmaceutical compositionsTRANSFORM PHARMACEUTICALS INC·Filed 2003·Granted Mar 29, 2011·1 cites·7 claims
- 1462US11518770B2Sesquiterpenoid analogsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Dec 6, 2022·0 cites·6 claims
- 1560US2019000801A1Methods of treating autoimmune and/or glomerulonephritis-associated diseases using shp2 inhibitorsINDIANA UNIV RESEARCH AND TECHNLOGY CORPORATION·Filed 2018·Application pending·0 cites
- 1656US10494332B2Protein tyrosine phosphatases or SHP2 inhibitors and uses thereofUNIV INDIANA RES & TECH CORP·Filed 2016·Granted Dec 3, 2019·0 cites·9 claims
- 1754US10532977B2Small molecule inhibitors of protein tyrosine phosphatases and uses thereofUNIV INDIANA RES & TECH CORP·Filed 2016·Granted Jan 14, 2020·0 cites·16 claims
- 1853US2006140985A1Lansoprazole formulations and related processes and methodsZHANG ZHONG·Filed 2004·Application pending·0 cites
- 1953US2004220283A1Aqueous 2,6-diisopropylphenol pharmaceutical compositionsTRANSFORM PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2052US9340574B2Inhibitors of protein tyrosine phosphatasesUNIV INDIANA RES & TECH CORP·Filed 2013·Granted May 17, 2016·0 cites·18 claims
- 2151US11192850B2N-aryl oxamic acidsPURDUE RESEARCH FOUNDATION·Filed 2021·Granted Dec 7, 2021·0 cites·8 claims
- 2250US11629130B2Lymphoid-specific tyrosine phosphatase (LYP) inhibitorsPURDUE RESEARCH FOUNDATION·Filed 2021·Granted Apr 18, 2023·0 cites·10 claims
- 2349US2004092428A1Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereofFiled 2002·Application pending·0 cites
- 2445US2007117851A1Liquid pharmaceutical compositions of nimodipineTRANSFORM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2544US2005070608A1Pharmaceutical compositions and method of using levodopa and carbidopaFiled 2004·Application pending·0 cites
- 2640US8071348B2Protein tyrosine phosphatase substrate-trapping double mutant and uses thereofZHANG ZHONG-YIN·Filed 2003·Granted Dec 6, 2011·0 cites·3 claims
- 2739US2004191926A1Ptp1b inhibitors and ligandsFiled 2002·Application pending·0 cites
- 2833US9493436B2Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosisZHANG ZHONG-YIN·Filed 2012·Granted Nov 15, 2016·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →